Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
The optimal blood pressure (BP) goal in patients with diabetes mellitus remains controversial. We examined whether benefits and risks of intensified antihypertensive therapy in diabetes mellitus are influenced by either baseline BP or cardiovascular disease (CVD) risk. We studied 10 948 people with...
Κύριοι συγγραφείς: | Rahman, F, McEvoy, J, Ohkuma, T, Marre, M, Hamet, P, Harrap, S, Mancia, G, Rodgers, A, Selvin, E, Williams, B, Muntner, P, Chalmers, J, Woodward, M |
---|---|
Μορφή: | Journal article |
Έκδοση: |
American Heart Association
2019
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Side-effects and tolerability of combination blood pressure lowering according to blood pressure levels – an analysis of the PROGRESS and ADVANCE trials
ανά: Atkins, A, κ.ά.
Έκδοση: (2017) -
Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial
ανά: Selvin, E, κ.ά.
Έκδοση: (2019) -
Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study
ανά: Ohkuma, T, κ.ά.
Έκδοση: (2017) -
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials
ανά: Czernichow, S, κ.ά.
Έκδοση: (2011) -
Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
ανά: Kengne, A, κ.ά.
Έκδοση: (2009)